Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maaya Akita"'
Autor:
Yoshihiro Kamada, Maaya Akita, Yuri Takeda, Shin Yamada, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hitomi Asazawa, Kotarosumitomo Nakayama, Kayo Mizutani, Hironobu Fujii, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Yasuharu Imai, Norifumi Kawada, Tetsuo Takehara, Eiji Miyoshi
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66328 (2013)
Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. NAFLD patients with nonalcoholic steatohepatitis (NASH) can develop cirrhosis and hepatocellular carcinoma. The ability to distinguish NASH from simple steatosis
Externí odkaz:
https://doaj.org/article/94493805052345049b4451e8919f156c
Autor:
Shinji Takamatsu, Eiji Miyoshi, Tetsuo Takehara, Yoshihiro Kamada, Maaya Akita, Naoko Terao, Kayo Mizutani, Hironobu Fujii, Yuichi Yoshida, Akiko Yamamoto, Sachiho Kida, Tomoaki Sobajima, Yusuke Ebisutani
Publikováno v:
Hepatology Research. 46:E118-E129
Aim Glycosylation changes induce various types of biological phenomena in human diseases. N-Acetylglucosaminyltransferase V (GnT-V) is one of the most important glycosyltransferases involved in cancer biology. Recently, many researchers have challeng
Autor:
Kayo Mizutani, Norifumi Kawada, Yuichi Yoshida, Yoshiyuki Sawai, Maaya Akita, Shinichi Kiso, Eiji Miyoshi, Yoshihiro Kamada, Masanori Miyazaki, Takayuki Yakushijin, Yoshinori Doi, Yasuharu Imai, Tetsuo Takehara, Naoki Hiramatsu, Sachiho Kida, Hideki Fujii, Noriaki Kinoshita, Nobuhiro Maruyama, Hironobu Fujii, Naofumi Uozumi, Hisao Ezaki, Motoya Sato
Publikováno v:
PROTEOMICS - Clinical Applications. 7:648-656
Purpose Mac-2 binding protein (Mac-2bp) is one of the major fucosylated glycoproteins, which we identified with glycol-proteomic analyses. We previously reported that fucosylated glycoproteins are secreted into bile, but scarcely secreted into sera i
Autor:
Yoshihiro, Kamada, Yusuke, Ebisutani, Sachiho, Kida, Kayo, Mizutani, Maaya, Akita, Akiko, Yamamoto, Hironobu, Fujii, Tomoaki, Sobajima, Naoko, Terao, Shinji, Takamatsu, Yuichi, Yoshida, Tetsuo, Takehara, Eiji, Miyoshi
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 46(3)
Glycosylation changes induce various types of biological phenomena in human diseases. N-Acetylglucosaminyltransferase V (GnT-V) is one of the most important glycosyltransferases involved in cancer biology. Recently, many researchers have challenged s
Autor:
Yoshio Sumida, Norifumi Kawada, Yoshihiro Kamada, Masafumi Ono, Hideki Fujii, Yuichi Yoshida, Hironobu Fujii, Kojiroh Mori, Saiyu Tanaka, Akiko Yamamoto, Maaya Akita, Eiji Miyoshi, Hideyuki Hyogo, Tetsuo Takehara, Yoshito Itoh, Shinji Takamatsu, Makoto Yamada, Kayo Mizutani, Toshiji Saibara, Kazuaki Chayama
Publikováno v:
Hepatology (Baltimore, Md.). 62(5)
Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem; thus, discriminating nonalcoholic steatohepatitis (NASH) from NAFLD is of great clinical significance. For the diagnosis of NASH, liver biopsy-proven histological examination is t
Autor:
Yuri Takeda, Hironobu Fujii, Kayo Mizutani, Sachiho Kida, Hidetaka Hougaku, Makoto Yamada, Motoya Sato, Eiji Miyoshi, Maaya Akita, Tetsuo Takehara, Yuka Ohara, Yuichi Yoshida, Yoshihiro Kamada
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 35(3)
Background & Aims Fetuin-A (α2HS-glycoprotein), a liver secretory glycoprotein, is known as a transforming growth factor (TGF)-β1 signalling inhibitor. Serum fetuin-A concentration is associated with nonalcoholic fatty liver disease (NAFLD) and car
Autor:
Kayo Mizutani, Yoshihiro Kamada, Maaya Akita, Hironobu Fujii, Shinji Takamatsu, Eiji Miyoshi, Yuka Ohara
Publikováno v:
Cancer Research. 74:886-886
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. Among NAFLD patients, those with nonalcoholic steatohepatitis (NASH) can develop cirrhosis and hepatocellular carcinoma (HCC). To distinguish N
Autor:
Shinichi Kiso, Yuri Takeda, Hideki Fujii, Masanori Miyazaki, Kotarosumitomo Nakayama, Hitomi Asazawa, Takayuki Yakushijin, Norifumi Kawada, Yuichi Yoshida, Yoshihiro Kamada, Hisao Ezaki, Shin Yamada, Eiji Miyoshi, Hironobu Fujii, Yoshinori Doi, Yasuharu Imai, Maaya Akita, Tetsuo Takehara, Yoshiyuki Sawai, Kayo Mizutani, Naoki Hiramatsu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 6, p e66328 (2013)
PLoS ONE, Vol 8, Iss 6, p e66328 (2013)
Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. NAFLD patients with nonalcoholic steatohepatitis (NASH) can develop cirrhosis and hepatocellular carcinoma. The ability to distinguish NASH from simple steatosis
Autor:
YOSHIHIRO KAMADA, MOTOYA SATO, SACHIHO KIDA, MAAYA AKITA, KAYO MIZUTANI, HIRONOBU FUJII, TOMOAKI SOBAJIMA, YUICHI YOSHIDA, SHINICHIRO SHINZAKI, SHINJI TAKAMATSU, TETSUO TAKEHARA, EIJI MIYOSHI
Publikováno v:
Molecular Medicine Reports; 2015, Vol. 11 Issue 5, p3573-3584, 12p